Pharmaceuticals
Ascensia Diabetes Care Showcases The Crucial Support Nurses Provide People With Diabetes To Celebrate World Diabetes Day 2020
BASEL, Switzerland, Nov. 13, 2020 /PRNewswire/ -- Ascensia Diabetes Care, a leading global diabetes care company and maker of the CONTOUR® range of blood glucose monitoring systems, is tomorrow celebrating the crucial role that nurses play in helping people manage their diabetes, as part of World...
2020-11-13 14:00
2908
Molecular Stethoscope Announces Completion of its NAFLD/NASH Study and Podium Presentation of Results by Dr. Naga Chalasani at the AASLD Liver Meeting 2020
Study results demonstrate the utility of the company's Next-Generation cf-mRNA Liquid Biopsy-Artificial Intelligence Technology Platform for the characterization of NAFLD/NASH disease PALO ALTO, Calif., Nov. 13, 2020 /PRNewswire/ -- Molecular Stethoscope, Inc., a precision medicine biotechnology...
2020-11-13 04:19
2005
Connect Biopharma Announces Appointment of Karen J. Wilson and Dr. Kleanthis G. Xanthopoulos to Board of Directors
SAN DIEGO and TAICANG, SUZHOU, China, Nov. 12, 2020 /PRNewswire/ -- Connect Biopharma, a clinical-stage biopharmaceutical company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune and inflammatory diseases, today announced the ap...
2020-11-12 21:00
2159
XJTLU launches new Academy of Pharmacy
SUZHOU, China, Nov. 12, 2020 /PRNewswire/ -- On 11 November 2020, Xi'an Jiaotong-Liverpool University launched its new XJTLU Wisdom Lake Academy of Pharmacy. "The biopharmaceutical industry is one of the fastest-growing sectors worldwide," says DrYimin Ding, Vice President of XJTLU. "It is als...
2020-11-12 15:13
2118
OrigiMed and Takeda Announced Partnership to Accelerate R&D and Commercialization of Innovative Medicines
* The collaboration will develop an innovative genomic-based clinical treatment platform * The goal of the collaboration is to accelerate the R&D and commercialization of innovative medicines SHANGHAI, Nov. 11, 2020 /PRNewswire/ --OrigiMed, a China-based leading precision medicine company and...
2020-11-11 21:26
7229
I-Mab Announces Preclinical Data on Differentiated Anti-C5aR Antibody TJ210/MOR210 at SITC 2020
SHANGHAI and GAITHERSBURG, Md., Nov. 11, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced new preclinical data fromin vivo and in vitro studies of...
2020-11-11 21:00
5260
Asieris Announces First Patient Administration in the Global Phase III Clinical Trial for APL-1702
SHANGHAI, Nov. 11, 2020 /PRNewswire/ -- Asieris Pharmaceuticals, a China-based biotech company with global aspirations to discover, develop, and commercialize innovative drugs for the treatment of genitourinary tumors and related diseases, announced today that the first patient was enrolled and a...
2020-11-11 17:08
1334
The IDAI Immunization Task Force Sets Priorities for Covid-19 Vaccine Emergency Use
* The emergency use authorization is only granted for limited use during the pandemic, not as a product distribution approval * Data on quality, both non-clinical and clinical, as well as the public health risks are the main considerations JAKARTA, Indonesia, Nov. 11, 2020 /PRNewswire/ -- Eme...
2020-11-11 12:51
1529
Holmusk partners with Merck to help improve outcomes for Diabetes & Prediabetes patients in Asia-Pacific
SINGAPORE, Nov. 11, 2020 /PRNewswire/ -- Singapore-based Holmusk announced a collaboration with the Healthcare business sector of Merck, a leading science and technology company to support patients and physicians inAsia-Pacific with a holistic treatment approach for prediabetes and diabetes. This...
2020-11-11 10:00
3530
Innovation Drives Excellence, Innovent Successfully Held 2020 Virtual R&D Day
SAN FRANCISCO and SUZHOU, China, Nov. 11, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for treatment of oncology, metabolic, autoimmune and other major diseas...
2020-11-11 08:00
8204
Innovent Releases Phase 1a Results of CD47 Monoclonal Antibody (Letaplimab) in Monotherapy for Advanced Malignancies at SITC 2020
SAN FRANCISCO, U.S. and SUZHOU, China, Nov. 11, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other ma...
2020-11-11 08:00
6907
FibroGenesis Announces the Filing of its 250th Patent for Fibroblast Cell Therapy Platform
World Leader in Fibroblast Technology Advances Intellectual Property Position with their 250th Patent Filed Today HOUSTON, Nov. 10, 2020 /PRNewswire/ -- FibroGenesis, a Texas-based regenerative medicine company focused on tissue regeneration and chronic disease reversal using Human Dermal Fibrob...
2020-11-10 22:37
1654
Bioheng Announced Oral Presentation of Its Preliminary Results of CRISPR-Engineered Allogeneic CAR-T for r/r B-ALL Treatment at 2020 ASH Meeting
HANGZHOU and NANJING, China, Nov. 10, 2020 /PRNewswire/ -- Bioheng Biotech Co., Ltd, a clinical-stage biotechnology company focuses on developing novel cellular immunotherapy, today announced that their preliminary data including the pre-clinical development, manufacturing, and investigator initi...
2020-11-10 22:30
1690
Volition Veterinary Presents Expert Report Ahead of First Product Launch
* A Look to the Future of Cancer Diagnostics compiles insight from four veterinary cancer experts * Report provides insight into the clinical impact of early cancer detection, and recent advances * Experts also reviewed data on the Nu.Q™ Vet Cancer Screening Test, providing opinion and guid...
2020-11-10 21:00
6291
Insilico announces a multi-target AI-powered drug discovery collaboration with Janssen
BEIJING, Nov. 10, 2020 /PRNewswire/ -- Insilico Medicine, a leader in deep generative reinforcement learning for target discovery, small molecule generation, and prediction of clinical trial outcomes, today announced that it entered into a multi-target drug discovery agreement with Janssen Pharma...
2020-11-10 09:00
2563
I-Mab Reports Phase 1 Clinical Trial Data of Highly Differentiated Anti-CD47 Monoclonal Antibody Lemzoparlimab at the 2020 SITC Annual Meeting
SHANGHAI and GAITHERSBURG, Md., Nov. 9, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced initial results from its U.S. phase 1 clinical trial (NCT...
2020-11-09 21:12
3910
Merck Announces Out-Licensing Agreement for Investigational Atacicept with Vera Therapeutics
Not intended for UK and US based media - Merck out-licenses Phase IIb-ready atacicept to Vera Therapeutics - Phase IIa trial conducted by Merck shows promising results in IgA nephropathy (IgAN), also known as "Berger's disease" - Out-licencing deal includes 10% equity in Vera Therapeutics and up...
2020-11-09 21:00
1683
Pierre Fabre initiates a "First in Human" clinical trial for an innovative monoclonal antibody (W0180) targeting the VISTA checkpoint in patients with solid tumors
TOULOUSE, France, Nov. 9, 2020 /PRNewswire/ -- Pierre Fabre announced today the initiation of an international Phase I clinical study in patients with relapsed or refractory solid tumors for its investigational product W0180, an innovative monoclonal antibody targeting VISTA, developed by Pierre ...
2020-11-09 20:57
2183
GenScript Receives FDA Emergency Use Authorization for World's First SARS-CoV-2 Neutralizing Antibody Detection Kit
PISCATAWAY, N.J., Nov. 9, 2020 /PRNewswire/ -- GenScript USA Inc., the world's
leading research reagent provider, announced today that the U.S. Food and Drug
Administration (FDA) has grantedEmergency Use Authorization (EUA)
2020-11-09 20:30
3843
TaiGen Partners with GPCR to develop Burixafor & Taigexyn(R)
TAIPEI, Nov. 9, 2020 /PRNewswire/ -- TaiGen Biotechnology Company, Limited ("TaiGen") announced today that they have signed an exclusive agreement with GPCR Therapeutics, Inc. ("GPCR"), a leading Korean biotechnology company, for the continued development of Burixafor worldwide and the commercial...
2020-11-09 18:22
1798
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
7433
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
2024-11-20 09:00
6834
